Comparison of First Year of Life Acute Otitis Media Admissions Before and After the 13-Valent Pneumococcal Conjugate Vaccine

Acute otitis media (AOM) is a common childhood infection, which is usually managed in the outpatient setting. Yet, the more severe cases are referred for inpatient treatment. We hypothesized that pneumococcal conjugate vaccines (PCVs), administered during the first year of life, would decrease AOM admissions rate in this age group. We studied the characteristics of infants admitted with AOM and acute mastoiditis (AM) in the PCV13 era, routinely given from November 2010 to all infants.

Source: International Journal of Pediatric Otorhinolaryngology - April 17, 2017 Category: ENT & OMF Authors: Tal Marom, Ofer Israel, Haim Gavriel, Jacob Pitaro, Ali Abo Baker, Ephraim Eviatar Source Type: research